Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
PCSK9 underexpression
i
Other names:
PCSK9, Proprotein Convertase Subtilisin/Kexin Type 9, NARC-1, Subtilisin/Kexin-Like Protease PC9, NARC1, Convertase Subtilisin/Kexin Type 9 Preproprotein, Hypercholesterolemia, Autosomal Dominant 3, Neural Apoptosis Regulated Convertase 1, Neural Apoptosis-Regulated Convertase 1, Proprotein Convertase 9, HCHOLA3, LDLCQ1, FHCL3
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
255738
Related biomarkers:
Expression
‹
PCSK9 expression (1)
PCSK9 expression (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
PCSK9 underexpression
Bladder Cancer
PCSK9 underexpression
Bladder Cancer
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
PCSK9 underexpression
Cutaneous Melanoma
PCSK9 underexpression
Cutaneous Melanoma
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
PCSK9 underexpression
Hepatocellular Cancer
PCSK9 underexpression
Hepatocellular Cancer
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
PCSK9 underexpression
Uveal Melanoma
PCSK9 underexpression
Uveal Melanoma
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
PCSK9 underexpression
Urothelial Cancer
PCSK9 underexpression
Urothelial Cancer
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
PCSK9 underexpression
Ovarian Cancer
PCSK9 underexpression
Ovarian Cancer
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
PCSK9 underexpression
Kidney Cancer
PCSK9 underexpression
Kidney Cancer
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
PCSK9 underexpression
Lung Adenocarcinoma
PCSK9 underexpression
Lung Adenocarcinoma
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.